Halog and Otezla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Halog (halcinonide) and Otezla (apremilast). Common drug interactions include psoriasis among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Halog and Otezla. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Halog?

Halog has active ingredients of halcinonide. eHealthMe is studying from 198 Halog users. Check the latest studies of Halog.

What is Otezla?

Otezla has active ingredients of apremilast. It is often used in psoriatic arthritis. eHealthMe is studying from 146,254 Otezla users. Check the latest studies of Otezla.

On Jul, 14, 2026

39 people who take Halog and Otezla together, and have interactions are studied.

What are the common drug interactions of Halog and Otezla, by gender? *:

female:

Psoriasis (immune-mediated disease that affects the skin)
Heart valve incompetence (heart's valves do not work correctly)
Diarrhoea
Nausea (feeling of having an urge to vomit)
Rash
Headache (pain in head)
Depression
Pruritus (severe itching of the skin)
Injection site reaction
Urticaria (rash of round, red welts on the skin that itch intensely)

male:

Drug ineffective
Psoriasis (immune-mediated disease that affects the skin)
Dry mouth
Dry throat
Memory impairment
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Diarrhoea
Depression
Rash

What are the common drug interactions of Halog and Otezla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Psoriasis (immune-mediated disease that affects the skin)
Rash

20-29:

Psoriasis (immune-mediated disease that affects the skin)

30-39:

Psoriasis (immune-mediated disease that affects the skin)
Alopecia (absence of hair from areas of the body)

40-49:

Nausea (feeling of having an urge to vomit)
Psoriasis (immune-mediated disease that affects the skin)
Depression
Diarrhoea
Drug ineffective
Headache (pain in head)
Memory impairment
Nasopharyngitis (inflammation of the nasopharynx)
Rash
Therapeutic response decreased (less preventive response)

50-59:

Drug ineffective
Head discomfort
Headache (pain in head)
Injection site reaction
Pruritus (severe itching of the skin)
Psoriasis (immune-mediated disease that affects the skin)
Rash

60+:

Diarrhoea
Drug ineffective
Tooth disorder (tooth disease)
Depression
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Dizziness
Insomnia (sleeplessness)
Pruritus (severe itching of the skin)
Psoriasis (immune-mediated disease that affects the skin)

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 31 people, 79.49%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Halog and Otezla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously